HOUSTON, Dec. 22, 2025 (GLOBE NEWSWIRE) -- CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of solid tumor cancer, today ...

Symptoms of stage 3 RCC vary; some patients experience blood in the urine, flank pain, fatigue, weight loss, or a palpable ...

The company has developed a method to detect circulating tumor DNA in surgical drain fluid from postoperative patients to detect molecular residual disease.

Urothelial carcinoma is a multifaceted malignancy that includes non–muscle-invasive bladder cancer (NMIBC) and upper tract ...

Osteoarthritis (OA) is a chronic degenerative joint disease marked by progressive cartilage breakdown, inflammation, and ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

Today, medical procedures often involve the use of a scalpel. However, American researchers have recently introduced the concept of “molecular surgery,” a novel method that utilizes electrical current ...